HTAi annual meeting
ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs
On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...
Insights From ISPOR 2025: R In Health Technology Assessment – Is It The Future?
ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and research in HEOR and market access. In this series, our experts share...
Navigating market access: Launch strategies and health economic modelling for medical devices – a live panel discussion
Discover how health economics can support successful Medical Device launch, proposition development, and market access. Join us live at 1:30pm (GMT) on Wednesday 19th March for an insightful journey into...
Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading
The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...
What does HEOR really mean in 2025?
Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...
Health economics training unpacked: A conversation with the trainers
Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma and Medtech teams upskill in key HEOR disciplines and prepare...
Challenges for orphan medicines entering the European market
We explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve patient access.
Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online
Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...
Mtech Access are exhibiting at ISPOR in Europe
• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...
Best practice RWE approaches to support economic modelling for HTA
How can real-world evidence (RWE) support health technology assessment (HTA)? Join the live webinar on Thursday 3rd October at 1.00pm (BST), featuring panellists from Mtech Access, Arcturis, and Delta Hat.
Surrogate endpoints in HTA: Reflections on my HTAi panel discussion
Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...
How does Genesis Research Group ‘Innovate differently’?
New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to 'Innovate differently' and transform the way they engage...